CollPlant Biotechnologies Ltd. (CLGN)
0.3203
-0.02
(-6.70%)
USD |
NASDAQ |
Sep 03, 16:00
0.3333
+0.01
(+4.06%)
After-Hours: 19:06
CollPlant Biotechnologies Gross Profit Margin (Quarterly) : -620.5% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -620.5% |
| December 31, 2025 | -580.0% |
| September 30, 2025 | -539.0% |
| June 30, 2025 | -131.8% |
| March 31, 2025 | 78.98% |
| December 31, 2024 | -213.4% |
| September 30, 2024 | -13.08K% |
| June 30, 2024 | -220.1% |
| March 31, 2024 | -741.8% |
| December 31, 2023 | -253.5% |
| September 30, 2023 | -1.18K% |
| June 30, 2023 | 91.35% |
| March 31, 2023 | -39.72% |
| December 31, 2022 | -513.8% |
| September 30, 2022 | -400.0% |
| June 30, 2022 | -360.6% |
| March 31, 2022 | -310.6% |
| December 31, 2021 | -76.77% |
| September 30, 2021 | -98.64% |
| June 30, 2021 | 37.92% |
| March 31, 2021 | 93.89% |
| December 31, 2020 | 39.32% |
| September 30, 2020 | 65.26% |
| June 30, 2020 | 9.11% |
| March 31, 2020 |
| Date | Value |
|---|---|
| December 31, 2019 | |
| September 30, 2019 | 5.01% |
| June 30, 2019 | 23.60% |
| March 31, 2019 | 31.82% |
| December 31, 2018 | 90.76% |
| September 30, 2018 | 36.51% |
| June 30, 2018 | 17.32% |
| March 31, 2018 | 50.69% |
| December 31, 2017 | 72.68% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | -39.64% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 65.15% |
| Perspective Therapeutics, Inc. | -1.31K% |
| MiMedx Group, Inc. | 68.50% |
| Regentis Biomaterials Ltd. | -- |
| Xylo Technologies Ltd. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -145.4% |
| Return on Assets | -95.59% |
| Return on Invested Capital | -110.4% |
| Profit Margin (Quarterly) | -4.24K% |
| Operating Margin (Quarterly) | -4.27K% |
| Return on Net Operating Assets | -267.2% |